Keywords: bioactive secondary metabolites; botcinins; botryotinia sp.; marine-derived fungus Marine microorganisms are recognized as an important source of structurally diverse bioactive secondary metabolites. 1,2 Studies of marine fungi as potential sources of new bioactive compounds have been relatively limited to date, but such studies have led to the discovery of new natural products, including many with novel carbon skeletons, providing compelling evidence that marine-derived fungi have the potential to be a rich source of pharmaceutical leads. 3,4 The insulin-antagonizing activity of protein tyrosine phosphatase 1B (PTP1B) is a factor in the negative regulation of the insulin pathway and a promising target for treatment of diabetes and obesity. Anchored to the endoplasmic reticulum, PTP1B is involved in the insulin receptor dephosphorylation process, negatively regulating insulin pathway signaling. 5,6 Several studies indicate that PTP1B is also implicated in the inhibition of leptin signaling, which inhibits food intake and promote energy expenditure. 7 As a part of our ongoing studies on PTP1B inhibitory secondary metabolites from marine microorganisms from Korea, we have investigated the chemical constituents of an extract obtained from cultures of the marine-derived fungus Botryotinia sp. SF-5275, of which the organic extract displayed PTP1B inhibitory effect (60% inhibition at the 30 mg ml À1 level). This paper describes the isolation, structure elucidation and biological activity of the metabolites encountered in this investigation.
agar (Bio Basics, Inc., Ontario, Canada) in 1 l of 75% filtered natural seawater. The plate was incubated at 25 1C for 14 days. The fungal culture SF-5275 was identified based on analysis of the ribosomal RNA (rRNA) sequences. A GenBank search with the 28S rRNA gene of SF-5275 (Genbank accession number HQ602686) indicated Botryotinia fuckeliana (AY544651) as the closest match showing sequence identity of 99%. Therefore, the marine-derived fungal strain SF-5275 was characterized as Botryotinia sp.
The fungal strain was cultured on 27 petri plates (90 mm), each containing 20 ml of potato dextrose agar medium (2.4% (w/v) potato dextrose broth, 2.0% (w/v) agar) prepared with 75% seawater. Plate cultures were incubated at 25 1C for 14 days. Extraction of the agar media with MEK (1 l) provided an organic phase, which was then concentrated in vacuo to yield 633 mg of an extract. This MEK extract was subjected to C 18 flash column chromatography (5Â40 cm, YMC ODS-A, S-75 mm, YMC Co., Ltd., Kyoto, Japan), eluting with a stepwise gradient of 20, 40, 60, 80 and 100% (v/v) MeOH in H 2 O (500 ml each). The fractions eluted at 80% (84.4 mg) and 100% MeOH (69.8 mg) were combined and purified by semi-preparative reversed-phase HPLC (Agilent prep-C 18 column (21.2Â150 mm; 5 mm particle size, Agilent Technologies, Santa Clara, CA, USA); flow rate of 5 ml/min; detection at 210 nm) eluting with a gradient from 70% to 90% MeOH in H 2 O (0.1% formic acid) over 60 min, then 100% MeOH for 20 min, to yield 1a (4.8 mg, t R ¼18.0 min), 1 (16.2 mg, t R ¼19.0 min) and 2 (11 mg, t R ¼32.0 min). The structures of previously known 1, 1a and 2 ( Figure 1) were elucidated by analysis of NMR and MS data, together with comparison of their spectral data with those in the literature. [8] [9] [10] In the course of biological and chemical studies of these compounds, the instability of botcinin A (1) in methanol solution was recognized, and the transformation of compound 1 was monitored in methanol over several days at room temperature by HPLC analysis (Supplementary Information). In this analysis, compound 1 was shown to be slowly converted to previously known 3-O-acetylbotcinic acid methyl ester (1a) and botcinin D (1b), which were identified upon isolation and subsequent structural analysis. This observation indicated that the hexahydropyrano[3,2,b]pyran-2(3 H)-one moiety in botcinin A (1) is particularly unstable in methanol, and undergoes both slow methanolysis and elimination of acetic acid under mild conditions. Analogs behavior was also observed for botcinin B (2), leading to the isolation and identification of additional new compounds designated 3-O-acetylbotcineric acid methyl ester (2a, Figure 1 ) and botcinin G (2b, Figure 1) . The molecular formula C 25 H 42 O 9 for 2a (Table 1) was suggested on the basis of NMR and HRESIMS data. The 13 C NMR and DEPT spectra of 2a were almost identical with those of 3-O-acetylbotcinic acid methyl ester (1a) except for the presence of signals corresponding to two additional methylene carbons (d C 29.0B31.7). This observation, together with the observed difference in mass, suggested that compound 2a possesses an alkyl chain with two additional methylene units as compared with that of compound 1a. Further interpretation of COSY, HSQC and HMBC NMR data for 2a (Table 2 ) allowed assignment of all 1 H and 13 C NMR resonances, and confirmed the proposed structure. Analysis of coupling constants and comparisons with corresponding values in compound 1a indicated that 2a has the same relative configuration as that of 3-O-acetylbotcinic acid methyl ester (1a). The molecular formula C 22 H 34 O 6 for compound 2b (Table 1) was suggested on the basis of NMR and HRESIMS data. The 13 C NMR and DEPT were very similar to those of botcinin D (1b) except for the presence of signals corresponding to two additional methylene units. This observation, together with the observed difference in mass, suggested that compound 2b possesses an alkyl chain with two additional methylene units as compared with that of compound 1b. Further interpretation of COSY, HSQC and HMBC NMR data (Table 2 ) of 2b allowed assignment of all 1 H and 13 C NMR resonances, and confirmed the suggested structure. The stereochemistry of compound 2b was suggested to be analogous to that of 1b on the basis of close similarities in relevant chemical shifts and J-values. As compounds 2a and 2b were derived from botcinin B (2), the absolute configurations of 2a and 2b were suggested to be analogous to that of 2. 8 The PTP1B inhibitory activities of the isolated compounds were evaluated in vitro, and, among the tested compounds, botcinin B (2) exhibited the strongest inhibitory activity in a dose-dependent manner, with an IC 50 value of 53.6 mM. The IC 50 value of compound 2b (96.2 mM) was Btwofold lower than that of 2. On the other hand, compounds 1 and 1b displayed much lower inhibitory effects, with IC 50 values of 340.7 mM and 461.2 mM, respectively, and compounds 1a and 2a did not show any inhibitory activity up to the 616.9 mM level. A known phosphatase inhibitor, ursolic acid (IC 50 ¼3.1 mM), was used as a positive control in the assay. 11 Although the magnitude of inhibitory activity of these compounds against PTP1B was modest, a structure-activity relationship was conferred upon examination of the structures and their corresponding activities. First, the length of the acyl chain appears to be important, because botcinin A (1) is less active than boticin B (2), whose acyl chain is longer than that of 1. A similar pattern was observed for compounds 1b and 2b. In addition, the presence of the hexahydropyrano[3,2,b]-pyran-2(3H)-one moiety was suggested to be an important structural feature for the inhibitory effect on PTP1B, because a loss (1 vs 1b and 2 vs 2b) or disappearance (1 vs 1a and 2 vs 2a) of inhibitory activity was observed with the degradation of this ring system in the respective compounds.
Next, the kinetics of PTP1B inhibition by 2 were explored, using different concentrations of a substrate in an effort to elucidate the mode of inhibition. When p-nitrophenyl phosphate (pNPP) was used as a substrate, compound 2 decreased the V max value, but did not alter the K m value of PTP1B (Figure 2 ). Therefore, it was shown that botcinin B (2) behaves as non-competitive inhibitors of PTP1B, implying that these compounds may bind to the enzyme-substrate complex or to an allosteric site within PTP1B. 12, 13 Botcinins are unusual bicyclic lactones containing a g-hydroxy-a,bunsaturated carboxylic acid, unit with an aliphatic alkyl chain, and were originally isolated from Botrytis cinerea as antifungal agents. 8, 9, 14 These compounds have been targets of asymmetric total synthesis, 15, 16 and the structure revision of boticinolides, previously reported as nine-membered lactones, to botcinin-type structures has been proposed. 9 In the study described here, PTP1B inhibitory effects of botcinins and related compounds were identified for the first time, and the chemical instability of botcinins A and B in methanol solution was recognized, leading to the identification of two new botcinin derivatives. 
